These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6255805)

  • 1. Prostaglandin synthesis inhibitors reverse alpha-adrenergic inhibition of acute insulin response to glucose.
    Metz SA; Robertson RP
    Am J Physiol; 1980 Dec; 239(6):E490-500. PubMed ID: 6255805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between epinephrine, prostaglandin E, and met-enkephalin in the regulation of insulin release in man.
    Giugliano D; Ceriello A; Quatraro A; Paolisso G; Varano R; D'Onofrio F
    Diabete Metab; 1985 Oct; 11(5):295-302. PubMed ID: 3908178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus.
    Robertson RP; Chen M
    J Clin Invest; 1977 Sep; 60(3):747-53. PubMed ID: 330566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts.
    Giugliano D; Quatraro A; Consoli G; Stante A; Simeone V; Ceriello A; Paolisso G; Torella R
    Acta Diabetol Lat; 1987; 24(3):205-12. PubMed ID: 3318257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrates tolerance.
    Chen M; Robertson RP
    Prostaglandins; 1979 Oct; 18(4):557-67. PubMed ID: 394200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucose-induced insulin secretion by indomethacin and sodium salicylate in the fetal lamb.
    Philipps AF; Matty PJ; Porte PJ; Raye JR
    Am J Obstet Gynecol; 1984 Feb; 148(4):481-7. PubMed ID: 6364813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release.
    Nakadate T; Nakaki T; Muraki T; Kato R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):226-30. PubMed ID: 6109015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for prostaglandins as mediators of alpha-adrenergic inhibition of the acute insulin response to glucose.
    Metz SA; Fujimoto WY; Robertson RP
    Adv Prostaglandin Thromboxane Res; 1980; 8():1291-4. PubMed ID: 6246779
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas.
    Metz SA; Robertson RP; Fujimoto WY
    Diabetes; 1981 Jul; 30(7):551-7. PubMed ID: 7018961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenergic modulation of glucagon and insulin secretions in sheep.
    Oda S; Fujimura H; Sasaki Y; Ohneda A
    Tohoku J Exp Med; 1991 Feb; 163(2):101-10. PubMed ID: 1675498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
    Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE
    Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
    Beard JC; Weinberg C; Pfeifer MA; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart.
    Doenst T; Taegtmeyer H
    Circ Res; 1999 Mar; 84(4):467-74. PubMed ID: 10066682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA; Vinik AI; Levitt N
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physiological infusion of epinephrine in normal humans: relationship between the metabolic response and beta-adrenergic binding.
    Soman VR; Shamoon H; Sherwin RS
    J Clin Endocrinol Metab; 1980 Feb; 50(2):294-7. PubMed ID: 6243667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic alpha- and beta-adrenergic receptors are not essential for the increase in R(a) during exercise in diabetes.
    Coker RH; Lacy DB; Williams PE; Wasserman DH
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E444-51. PubMed ID: 10710498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.